Integrating cfDNA liquid biopsy and organoid-based drug screening reveals PI3K signaling as a promising therapeutic target in colorectal cancer.
J Transl Med
; 22(1): 132, 2024 02 03.
Article
in En
| MEDLINE
| ID: mdl-38310289
Full text:
1
Database:
MEDLINE
Main subject:
Colorectal Neoplasms
/
Cell-Free Nucleic Acids
Type of study:
Diagnostic_studies
/
Prognostic_studies
/
Screening_studies
Language:
En
Journal:
J Transl Med
Year:
2024
Type:
Article
Affiliation country:
China